Article by QFINITY’s Sr. Exc. Consultant ranks 3rd most read article in Clinical Supplier Leader

We are pleased to announce that Frank Henrichmann’s article was the third most-read article on the Clinical Supplier Leader platform in October. The topic of the article was ‘Massive Data, More Decentralisation Drive Updates To ISPE GAMP Guide’. This emphasizes the relevance of the article for the clinical research and development community.

The article highlights the need for a new version of the ISPE GAMP Guide. Mr. Henrichmann addresses the far-reaching changes in the clinical data landscape. He focuses on risk-based system validations in the context of Good Clinical Practice. He provides insights and recommendations to support various clinical trial stakeholders in overcoming new challenges and utilizing modern data architectures.

We at QFINITY see the high response to Mr. Henrichmann’s article as confirmation of the importance of up-to-date and practical information for pharmaceutical and clinical research. It shows how important the dialogue about innovative, decentralized data systems and the adaptation to new regulatory requirements is.

Congratulations to Frank Henrichmann on this recognition of his work, which provides valuable impetus for the industry!

You can find the full interview here. Further information on the Clinical Supply Leader placement can be found here.

Check our News Site for more information about QFINITY´s work.